Healthpeak Properties Overview
Healthpeak Properties Target Price
Analysts' 12-month price predictions for DOC.
Share Price
$17.73
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-10-21 | Deutsche BankOmotayo Okusanya | $28 |  57.9% upside |  |
| 2024-08-21 | CitigroupNick Joseph | $22 | 24.1% upside | |
| 2024-07-30 | Robert W. BairdWesley Golladay | $24 | 35.4% upside | |
| 2024-07-30 | RBC CapitalMichael Carroll | $25 | 41% upside | |
| 2024-05-03 | WedbushRichard Anderson | $22 | 24.1% upside | |
| 2024-04-10 | RBC CapitalMichael Carroll | $22 | 24.1% upside | |
| 2024-03-27 | Robert W. Baird | $22 | 24.1% upside | |
| 2024-03-25 | Wells FargoConnor Siversky | $19 | 7.2% upside | |
| 2023-08-01 | Credit SuisseOmotayo Okusanya | $15 |  15.4% downside | |
| 2022-08-31 | Morgan Stanley | $16.5 | 6.9% downside | |
| 2022-07-15 | Morgan Stanley | $16 | 9.8% downside | |
| 2022-07-11 | Truist Financial | $17 | 4.1% downside | |
| 2022-06-30 | Jefferies | $20 | 12.8% upside | |
| 2022-06-01 | Morgan Stanley | $17.5 | 1.3% downside | |
| 2022-04-26 | Barclays | $20 | 12.8% upside | |
| 2021-05-06 | Truist FinancialMichael R Lewis | $19 | 7.2% upside | |